Kenny L - Search Results

1

Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence.

Coombes RC, Page K, Salari R, Hastings RK, Armstrong A, Ahmed S, Ali S, Cleator S, Kenny L, Stebbing J, Rutherford M, Sethi H, Boydell A, Swenerton R, Fernandez-Garcia D, Gleason KLT, Goddard K, Guttery DS, Assaf ZJ, Wu HT, Natarajan P, Moore DA, Primrose L, Dashner S, Tin AS, Balcioglu M, Srinivasan R, Shchegrova SV, Olson A, Hafez D, Billings P, Aleshin A, Rehman F, Toghill BJ, Hills A, Louie MC, Lin CJ, Zimmermann BG, Shaw JA. Coombes RC, et al. Among authors: kenny l. Clin Cancer Res. 2019 Jul 15;25(14):4255-4263. doi: 10.1158/1078-0432.CCR-18-3663. Epub 2019 Apr 16. Clin Cancer Res. 2019. PMID: 30992300

2

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods.

Kenny LM, Vigushin DM, Al-Nahhas A, Osman S, Luthra SK, Shousha S, Coombes RC, Aboagye EO. Kenny LM, et al. Cancer Res. 2005 Nov 1;65(21):10104-12. doi: 10.1158/0008-5472.CAN-04-4297. Cancer Res. 2005. PMID: 16267037

3

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

Kenny L, Coombes RC, Vigushin DM, Al-Nahhas A, Shousha S, Aboagye EO. Kenny L, et al. Eur J Nucl Med Mol Imaging. 2007 Sep;34(9):1339-47. doi: 10.1007/s00259-007-0379-4. Epub 2007 Mar 2. Eur J Nucl Med Mol Imaging. 2007. PMID: 17333178

4

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients.

Kenny LM, Coombes RC, Oulie I, Contractor KB, Miller M, Spinks TJ, McParland B, Cohen PS, Hui AM, Palmieri C, Osman S, Glaser M, Turton D, Al-Nahhas A, Aboagye EO. Kenny LM, et al. J Nucl Med. 2008 Jun;49(6):879-86. doi: 10.2967/jnumed.107.049452. Epub 2008 May 15. J Nucl Med. 2008. PMID: 18483090 Free article. Clinical Trial.

5

[11C]choline positron emission tomography in estrogen receptor-positive breast cancer.

Contractor KB, Kenny LM, Stebbing J, Al-Nahhas A, Palmieri C, Sinnett D, Lewis JS, Hogben K, Osman S, Shousha S, Lowdell C, Coombes RC, Aboagye EO. Contractor KB, et al. Clin Cancer Res. 2009 Sep 1;15(17):5503-10. doi: 10.1158/1078-0432.CCR-09-0666. Epub 2009 Aug 25. Clin Cancer Res. 2009. PMID: 19706823

6

Altered tissue 3'-deoxy-3'-[18F]fluorothymidine pharmacokinetics in human breast cancer following capecitabine treatment detected by positron emission tomography.

Kenny LM, Contractor KB, Stebbing J, Al-Nahhas A, Palmieri C, Shousha S, Coombes RC, Aboagye EO. Kenny LM, et al. Clin Cancer Res. 2009 Nov 1;15(21):6649-57. doi: 10.1158/1078-0432.CCR-09-1213. Epub 2009 Oct 27. Clin Cancer Res. 2009. PMID: 19861447

7

Kinetic filtering of [(18)F]Fluorothymidine in positron emission tomography studies.

Gray KR, Contractor KB, Kenny LM, Al-Nahhas A, Shousha S, Stebbing J, Wasan HS, Coombes RC, Aboagye EO, Turkheimer FE, Rosso L. Gray KR, et al. Among authors: kenny lm. Phys Med Biol. 2010 Feb 7;55(3):695-709. doi: 10.1088/0031-9155/55/3/010. Epub 2010 Jan 13. Phys Med Biol. 2010. PMID: 20071760

8

Reproducibility of [11C]choline-positron emission tomography and effect of trastuzumab.

Kenny LM, Contractor KB, Hinz R, Stebbing J, Palmieri C, Jiang J, Shousha S, Al-Nahhas A, Coombes RC, Aboagye EO. Kenny LM, et al. Clin Cancer Res. 2010 Aug 15;16(16):4236-45. doi: 10.1158/1078-0432.CCR-10-0468. Epub 2010 Aug 3. Clin Cancer Res. 2010. PMID: 20682702 Clinical Trial.

9

Biological basis of [¹¹C]choline-positron emission tomography in patients with breast cancer: comparison with [¹⁸F]fluorothymidine positron emission tomography.

Contractor KB, Kenny LM, Stebbing J, Challapalli A, Al-Nahhas A, Palmieri C, Shousha S, Lewis JS, Hogben K, De Nguyen Q, Coombes RC, Aboagye EO. Contractor KB, et al. Nucl Med Commun. 2011 Nov;32(11):997-1004. doi: 10.1097/MNM.0b013e328349567b. Nucl Med Commun. 2011. PMID: 21862943

10

[18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.

Contractor KB, Kenny LM, Stebbing J, Rosso L, Ahmad R, Jacob J, Challapalli A, Turkheimer F, Al-Nahhas A, Sharma R, Coombes RC, Aboagye EO. Contractor KB, et al. Among authors: kenny lm. Clin Cancer Res. 2011 Dec 15;17(24):7664-72. doi: 10.1158/1078-0432.CCR-11-0783. Epub 2011 Oct 25. Clin Cancer Res. 2011. PMID: 22028493 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

625 results

Search Page